Marvel Biosciences Corp is a life sciences company focused on the discovery and the development of a synthetic derivative compound of a known proven drug. It has developed several new patented and patentable chemical entities, using synthetic chemical derivatives of known, off-patent drugs, that inhibit the A2a adenosine receptor with application to neurological diseases (depression and anxiety, Alzheimer's, ADHD and addiction), cancer, and application to the non-neurological disease of non-alcoholic steatohepatitis liver fibrosis.
Chart
Detailed Quote
CEO Interviews
Featured Articles and Interviews
Press Releases
INNspired
INN Disclaimer: This profile is sponsored by Marvel Biosciences Corp. ( TSXV:MRVL ). This profile provides information which was sourced by the Investing News Network (INN) and approved by Marvel Biosciences Corp. in order to help investors learn more about the company. Marvel Biosciences Corp. is a client of INN. The company's campaign fees pay for INN to create and update this profile.
INN does not provide investment advice and the information on this profile should not be considered a recommendation to buy or sell any security. INN does not endorse or recommend the business, products, services or securities of any company profiled.
This profile contains forward-looking information, including statements regarding planned activities, timelines, business objectives, and market conditions. Forward-looking information is based on assumptions and is subject to known and unknown risks and uncertainties that may cause actual results to differ materially from those anticipated. Readers should not place undue reliance on forward-looking information, which reflects the views of the profiled company as of the date of this profile and is not updated by INN.
The information contained here is for information purposes only and is not to be construed as an offer or solicitation for the sale or purchase of securities. In exchange for publishing services rendered by INN on behalf of Marvel Biosciences Corp. named herein, including the promotion by INN of Marvel Biosciences Corp. in any content on the INN website, the INN receives from Marvel Biosciences Corp. annual cash compensation of typically up to two hundred and fifty thousand dollars. Readers should conduct their own research for all information publicly available concerning the company. Prior to making any investment decision, it is recommended that readers consult directly with Marvel Biosciences Corp. and seek advice from a qualified investment advisor.
Alert Options
No alert set